Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms [+1]
Patients who lack decisional capacity [+3]